Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound activated daemonorops draco

A technology of dried blood and compound recipes, which can be applied in medical formulas, diseases of the cardiovascular system, medical preparations containing active ingredients, etc., can solve the problems of undiscovered total saponins of Panax notoginseng and the synergistic effect of dried blood, and achieve the improvement of potency Effect

Inactive Publication Date: 2005-07-27
云南圣科药业有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, there are many literature reports on various drugs for the treatment of cardiovascular and cerebrovascular diseases made by combining Panax notoginseng saponins, dried blood and other ingredients. Among the medicines formed by the compatibility, no significant effect of Panax notoginsenosides and dried blood has been found. Synergy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Take 1,500 grams of β-cyclodextrin inclusion compound of jeremiad japonicus and 1,500 grams of total saponins of Panax notoginseng, add appropriate amount of excipients, mix well, fill and make 10,000 capsules.

Embodiment 2

[0017] Get 2000 grams of β-cyclodextrin inclusion complex, 1000 grams of Panax notoginseng saponins, appropriate amount of excipients, mix to make soft granules, dry, compress into tablets, and make 10000 tablets for oral administration.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a compound medicine preparation-compound activated dragon's blood with the functions of curing and preventing coronary heart disease, angina pectoris, hypertension and hyperlipemia, etc. It is characterized by that its effective medicinal component is formed dragon's blood inclusion compound and notoginseng total saponin, in which the weight percentage of the dragon's blood inclusion compound is 20-80% of that of said compound medicine preparation, and the weight percentage of the notoginseng total saponin is 80-20% of that of said compound medicine preparation.

Description

technical field [0001] The invention relates to a medicine for treating cardiovascular and cerebrovascular diseases, especially a compound preparation made of extracts from natural plants. technical background [0002] Panax notoginseng saponins have become a well-known anti-cardiocerebral ischemia drug in clinical practice. Many basic and clinical studies have been carried out in the treatment of cardiovascular diseases, showing that it has anti-myocardial ischemia, anti-shock, and anti-arrhythmia effects. And inhibit the proliferation of vascular smooth muscle cells and other pharmacological effects, can treat coronary heart disease, hypertension, hyperlipidemia, etc., is a good medicine for the treatment and prevention of cardiovascular diseases. In addition to its pharmacology, efficacy and clinical efficacy similar to that of notoginseng saponins, dried blood contains dozens of flavonoids, which show anti-oxidant free radicals, reduce hyperlipidemia, antibacterial and a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61P9/10
Inventor 周家礽汪伯良陈植和
Owner 云南圣科药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com